Aktiengesellschaft Bayer's Net Worth
Aktiengesellschaft Bayer's net worth is estimated to be at least $1,638,279,988.00 as of 11/23/2024. CoreStreet's estimation of Aktiengesellschaft Bayer's net worth is based on their sale of stock and current holding of stock.
Aktiengesellschaft Bayer is Major Shareholder at Elanco Animal Health. They have executed at least 2 trades of stock as per SEC Form 4 filings. Their most recent trade was for 54,500,000 units of ELAN stock on 12/03/2020. Their biggest sale was on 12/03/2020 when they sold 54,500,000 units of Elanco Animal Health stock for $1,626,280,000.00. They typically trade 1 times per year.
Total value of insider buys:
- $11,999,988.00
Total value of insider sells:
- $1,626,280,000.00
Most recent insider trade:
- Dec. 3, 2020
Aktiengesellschaft Bayer's Insider Trading History
| Elanco Animal Health | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 3, 2020 | Major Shareholder | 54,500,000 | $29.84 | Sell | $1,626,280,000.00 |
| Crispr Therapeutics AG | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 5, 2018 | Major Shareholder | 527,472 | $22.75 | Buy | $11,999,988.00 |